Sushant Kumar
Founder at Tarus Therapeutics, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Paolo Pucci | M | 63 |
Tarus Therapeutics, Inc.
Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Tarus Therapeutics, Inc. is a company developing small molecule inhibitors of adenosine receptors for cancer immunotherapy and select non-oncology indications. The company is based in New York, NY. The company has a comprehensive portfolio of adenosine receptor antagonists in development, including both first-in-class and programs. The company was founded by Sushant Kumar and Peter R. Molloy, with Sushant Kumar serving as CEO since incorporation. Tarus Therapeutics was acquired by Portage Biotech, Inc. on July 05, 2022 for $49.20 million. | 4 years |
Peter Molloy | M | 52 |
Tarus Therapeutics, Inc.
Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Tarus Therapeutics, Inc. is a company developing small molecule inhibitors of adenosine receptors for cancer immunotherapy and select non-oncology indications. The company is based in New York, NY. The company has a comprehensive portfolio of adenosine receptor antagonists in development, including both first-in-class and programs. The company was founded by Sushant Kumar and Peter R. Molloy, with Sushant Kumar serving as CEO since incorporation. Tarus Therapeutics was acquired by Portage Biotech, Inc. on July 05, 2022 for $49.20 million. | - |
David Epstein | M | 62 |
Tarus Therapeutics, Inc.
Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Tarus Therapeutics, Inc. is a company developing small molecule inhibitors of adenosine receptors for cancer immunotherapy and select non-oncology indications. The company is based in New York, NY. The company has a comprehensive portfolio of adenosine receptor antagonists in development, including both first-in-class and programs. The company was founded by Sushant Kumar and Peter R. Molloy, with Sushant Kumar serving as CEO since incorporation. Tarus Therapeutics was acquired by Portage Biotech, Inc. on July 05, 2022 for $49.20 million. | 4 years |
Robert Glassman | M | 62 |
Tarus Therapeutics, Inc.
Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Tarus Therapeutics, Inc. is a company developing small molecule inhibitors of adenosine receptors for cancer immunotherapy and select non-oncology indications. The company is based in New York, NY. The company has a comprehensive portfolio of adenosine receptor antagonists in development, including both first-in-class and programs. The company was founded by Sushant Kumar and Peter R. Molloy, with Sushant Kumar serving as CEO since incorporation. Tarus Therapeutics was acquired by Portage Biotech, Inc. on July 05, 2022 for $49.20 million. | 3 years |
C. Nicholson | M | 68 |
Tarus Therapeutics, Inc.
Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Tarus Therapeutics, Inc. is a company developing small molecule inhibitors of adenosine receptors for cancer immunotherapy and select non-oncology indications. The company is based in New York, NY. The company has a comprehensive portfolio of adenosine receptor antagonists in development, including both first-in-class and programs. The company was founded by Sushant Kumar and Peter R. Molloy, with Sushant Kumar serving as CEO since incorporation. Tarus Therapeutics was acquired by Portage Biotech, Inc. on July 05, 2022 for $49.20 million. | 4 years |
Mark S. Cohen | M | 56 |
Tarus Therapeutics, Inc.
Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Tarus Therapeutics, Inc. is a company developing small molecule inhibitors of adenosine receptors for cancer immunotherapy and select non-oncology indications. The company is based in New York, NY. The company has a comprehensive portfolio of adenosine receptor antagonists in development, including both first-in-class and programs. The company was founded by Sushant Kumar and Peter R. Molloy, with Sushant Kumar serving as CEO since incorporation. Tarus Therapeutics was acquired by Portage Biotech, Inc. on July 05, 2022 for $49.20 million. | 3 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Darshana P. Kalikstein | F | - |
Mehta Partners LLC
Mehta Partners LLC Investment ManagersFinance Founded in 1980, Mehta Partners LLC is a research firm located in New York City. The universe Mehta monitors includes biopharmaceutical companies in the U.S., Europe, Japan and emerging markets including Brazil, China, Eastern Europe and India. They cover 400 companies that are classified by geography and maturity. | - |
Ajay Bansal | M | 62 |
Mehta Partners LLC
Mehta Partners LLC Investment ManagersFinance Founded in 1980, Mehta Partners LLC is a research firm located in New York City. The universe Mehta monitors includes biopharmaceutical companies in the U.S., Europe, Japan and emerging markets including Brazil, China, Eastern Europe and India. They cover 400 companies that are classified by geography and maturity. | 4 years |
Peter Charles Forde | M | 69 |
Mehta Partners LLC
Mehta Partners LLC Investment ManagersFinance Founded in 1980, Mehta Partners LLC is a research firm located in New York City. The universe Mehta monitors includes biopharmaceutical companies in the U.S., Europe, Japan and emerging markets including Brazil, China, Eastern Europe and India. They cover 400 companies that are classified by geography and maturity. | 2 years |
Ilya Kravets | M | - |
Mehta Partners LLC
Mehta Partners LLC Investment ManagersFinance Founded in 1980, Mehta Partners LLC is a research firm located in New York City. The universe Mehta monitors includes biopharmaceutical companies in the U.S., Europe, Japan and emerging markets including Brazil, China, Eastern Europe and India. They cover 400 companies that are classified by geography and maturity. | 5 years |
Nimish Mehta | M | - |
Mehta Partners LLC
Mehta Partners LLC Investment ManagersFinance Founded in 1980, Mehta Partners LLC is a research firm located in New York City. The universe Mehta monitors includes biopharmaceutical companies in the U.S., Europe, Japan and emerging markets including Brazil, China, Eastern Europe and India. They cover 400 companies that are classified by geography and maturity. | 2 years |
Tarun Shah | M | - |
Mehta Partners LLC
Mehta Partners LLC Investment ManagersFinance Founded in 1980, Mehta Partners LLC is a research firm located in New York City. The universe Mehta monitors includes biopharmaceutical companies in the U.S., Europe, Japan and emerging markets including Brazil, China, Eastern Europe and India. They cover 400 companies that are classified by geography and maturity. | 2 years |
Shao Jing Tong | M | 53 |
Mehta Partners LLC
Mehta Partners LLC Investment ManagersFinance Founded in 1980, Mehta Partners LLC is a research firm located in New York City. The universe Mehta monitors includes biopharmaceutical companies in the U.S., Europe, Japan and emerging markets including Brazil, China, Eastern Europe and India. They cover 400 companies that are classified by geography and maturity. | 4 years |
Kenneth Wahl | M | - |
Mehta Partners LLC
Mehta Partners LLC Investment ManagersFinance Founded in 1980, Mehta Partners LLC is a research firm located in New York City. The universe Mehta monitors includes biopharmaceutical companies in the U.S., Europe, Japan and emerging markets including Brazil, China, Eastern Europe and India. They cover 400 companies that are classified by geography and maturity. | 4 years |
Hui Shao | M | 55 |
Mehta Partners LLC
Mehta Partners LLC Investment ManagersFinance Founded in 1980, Mehta Partners LLC is a research firm located in New York City. The universe Mehta monitors includes biopharmaceutical companies in the U.S., Europe, Japan and emerging markets including Brazil, China, Eastern Europe and India. They cover 400 companies that are classified by geography and maturity. | 3 years |
Bhavesh Patel | M | - |
Mehta Partners LLC
Mehta Partners LLC Investment ManagersFinance Founded in 1980, Mehta Partners LLC is a research firm located in New York City. The universe Mehta monitors includes biopharmaceutical companies in the U.S., Europe, Japan and emerging markets including Brazil, China, Eastern Europe and India. They cover 400 companies that are classified by geography and maturity. | - |
Manushi Naik | F | - |
Mehta Partners LLC
Mehta Partners LLC Investment ManagersFinance Founded in 1980, Mehta Partners LLC is a research firm located in New York City. The universe Mehta monitors includes biopharmaceutical companies in the U.S., Europe, Japan and emerging markets including Brazil, China, Eastern Europe and India. They cover 400 companies that are classified by geography and maturity. | - |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 17 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Sushant Kumar
- Personal Network